drug discovery
Artificial Intelligence
MIT researchers introduce Boltz-1, a completely open-source model for predicting biomolecular structures
MIT scientists have released a strong, open-source AI model, called Boltz-1, that might...
Artificial Intelligence
AI-Driven Drug Discovery Achieves Milestone with Insilico Medicine’s Phase IIa Success in Treating Pulmonary Fibrosis
In a breakthrough for AI-powered drug discovery, Insilico Medicine announced positive Phase IIa results for its novel drug ISM001-055, designed to treat Idiopathic Pulmonary Fibrosis (IPF). This small molecule, developed using Insilico’s proprietary generative...
Artificial Intelligence
Beyond the Hype: Unveiling the Real Impact of Generative AI in Drug Discovery
Since Insilico Medicine developed a drug for idiopathic pulmonary fibrosis (IPF) using generative AI, there's been a growing excitement about how this technology could change drug discovery. Traditional methods are slow and expensive, so...
Artificial Intelligence
Decoding the Language of Molecules: How Generative AI is Accelerating Drug Discovery
As generative AI evolves, it moves beyond deciphering human language to mastering the intricate languages of biology and chemistry. Consider DNA as a detailed script, a 3-billion-letter sequence that guides our body's functions and...
Artificial Intelligence
Quantum-Enhanced AI Revolutionizes Cancer Drug Discovery: A Leap Forward with Industrial Generative AI
In an unprecedented advancement in drug discovery, Zapata Computing, Inc., alongside Insilico Medicine, the University of Toronto, and St. Jude Kid's Research Hospital, has showcased the remarkable potential of quantum-enhanced generative AI. This collaboration...
Artificial Intelligence
Learning the language of molecules to predict their properties
Discovering recent materials and medicines typically involves a manual, trial-and-error process that...
Recent posts
